Abstract In 2015, the National Institutes of Health convened six working groups to address
the research needs and best practices for late effects of hematopoietic stem cell …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has become increasingly
used as a therapeutic treatment for several pediatric conditions, however the long-term …

Corticosteroid can induce osteonecrosis in children with leukemia. Few studies have been
designed to assess the influence of a wide range of cumulative steroid dose on this side …

Purpose This study explored the relationships among self-efficacy, post-traumatic growth,
and quality of life in a sample of pediatric cancer survivors and analyzed the factors …

Patient-reported outcomes among survivors of pediatric hematopoietic stem cell transplant
(HSCT) are understudied. We compared symptom prevalence, health-related quality of life …

Importance Significant advancements in pediatric oncology have led to a continuously
growing population of survivors. Although extensive research is being conducted on the …

Despite advances in haematopoietic stem cell transplant (HSCT) techniques, the risk of
serious side effects and complications still exists. Neurological complications, both acute …

Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease
relapse and failure of conventional treatments for cancer in childhood or as a first line …

Background Pediatric CML is very rare. Before the introduction of tyrosine kinase inhibitors
(TKIs), allogeneic hematopoietic stem cell transplantation (HSCT) from a donor-if available …

Background Adolescent hematopoietic cell transplant (HCT) recipients remain out of school
for a prolonged period of time; navigating their return to school after completion of therapy …